Yoko Nakanishi

Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry

Gou Mizutani, Yoko Nakanishi, Noriko Watanabe et al. · ACTA HISTOCHEMICA ET CYTOCHEMICA · 2012 · 91 citations · Full text

Tumor Innervation, Medicine, Real-time Rt-pcr Method +12

Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomas

Kyoko Komatsu, Yoko Nakanishi, Norimichi Nemoto et al. · Brain Tumor Pathology · 2004 · 84 citations

Matrix Metalloproteinase-2 And-9, Neuro-oncology, Medicine +9

Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane

Yuko Iida, Mayumi Okamoto-Κatsuyama, Shuichiro Maruoka et al. · Oncology Letters · 2020 · 77 citations · Full text

Clinicopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue - immunohistochemical analysis of 67 lesions

Yuko Ono, Yoko Nakanishi, Yoshihiko Ino et al. · International Journal of Oral and Maxillofacial Surgery · 2000 · 70 citations

Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer

Tetsuyo Maeda, Yoko Nakanishi, Yukari Hirotani et al. · Medical Molecular Morphology · 2015 · 52 citations

Androgen Receptor, Breast Oncology, Medicine +9